BODE Index (COPD Prognosis)
iatroX editorial team · Updated · Record checked · editorial policy
The BODE index is a multidimensional COPD prognostic score incorporating Body mass index, airflow Obstruction (FEV₁), Dyspnoea (mMRC), and Exercise capacity (6MWD). It predicts mortality better than FEV₁ alone.
inputs
evidence
derivation
Developed by Celli et al. (NEJM 2004) from 625 COPD patients followed for up to 5 years at multiple centres.
validation
BODE predicted mortality better than FEV₁ alone (AUROC 0.74 vs 0.65). BODE quartile 4 (7–10) had 80% 4-year mortality vs 20% for quartile 1 (0–2). Validated in multiple international cohorts. Used in transplant referral guidelines.
guideline endorsements
GOLD 2025 Report references BODE for prognosis. ISHLT transplant listing guidelines reference BODE ≥5–6. ATS/ERS COPD outcome measures reference BODE.
references
- Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. NEJM. 2004;350(10):1005-1012.PMID: 14999112
- Global Initiative for Chronic Obstructive Lung Disease (GOLD). 2025 Report.link ↗